Max J Thompson
38th Lorne Cancer Conference 2026
Days
Thursday, 12th February
Friday, 13th February
Saturday, 14th February
Search
Speakers
Max J Thompson
PhD Candidate at Mater Research with Tumour Biology and Therapeutics Research (K. K. Khanna Laboratory).
Abstracts this author is presenting:
CHK1 inhibitor with low dose Hydroxyurea Amplifies Replication Stress and Drives a Novel Pan-nuclear Ataxia Telangiectasia Mutated Phenotype
—
Poster Session 2
